TOC | GI
Irritable Bowel Syndrome ibs2008.pdf
DX | RX
See Johns Hopkins IBS Resource Site | IBS2011.pdf
IBS is a very common, chronic, recurring GI disorder without cure and without dire consequences. It is a benign disease. The cause of IBS is only incompletely understood. Currently, IBS is believed to represent a complex of abnormal gastrointestinal motility, altered visceral sensation, and psychologic factors. Emotional stress may alter small and large bowel function in normal people, and it does so to a much greater extent in people with IBS.
SX: chronic recurrent crampy abdominal pain, bloating, excessive flatulence, diarrhea, constipation, or alternating diarrhea and constipation.
Although IBS is ultimately a diagnosis of exclusion, certain features, including stable weight, chronic GI symptoms, and an unrevealing physical examination, often allow a presumptive diagnosis and initiation of treatment without extensive diagnostic testing.
(The Rome Criteria for Irritable Bowel Syndrome - Gastroent Int 1992; 5:75 Thompson WG, Creed F)
At least 3 months of continuous or recurrent symptoms of
The Manning Criteria for Irritable Bowel Syndrome:
- Pain relieved by defecation
- Looser stools at onset of pain
- More frequent bowel movements at onset of pain
- Abdominal distension (visible)
- Mucus per rectum
- Feeling of incomplete rectal emptying
Approach to IBS
H & P to rule out organic cause of the symptoms as drugs, dietary habits, lactose intolerance, weight loss, bleeding, anemia, fever, colon inflammation, infection, or malignancy, biliary disease, previous GI surgery, etc. History should also include emotional stress profile.
Diff-Diagnosis of IBS:
Lab: CBC, glucose, BUN, Creat, liver enzymes, amylase, protein, calcium, stool exam, etc. Sigmoidoscopy & Barium enema, UGI with Small Bowell Follow Through if not done before; other diagnostic tests per clinical suspicion.
Management of IBS
Educate & reassure the patient about
the benign nature of the IBS, once the disgnosis is firm. Stress
management, anxiety & depression therapy if needed.
Repeated reassurance that the test results are normal often have considerable therapeutic benefit. Another important aspect in the management of the patient with IBS is the instillation of realistic expectations for long-term symptomatic improvement. This process of patient education and repeated reassurance may, in the long run, be the single most effective intervention the physician makes.
High fiber diet 30 g/day with adequate fluid intake.
Drug symptomatic therapy:
* Among patients who had IBS without constipation, treatment with rifaximin
at a dose of 550 mg, three times daily for 2 weeks provided significant relief
of IBS symptoms, bloating, abdominal pain, and loose or watery stools.
Significantly more patients in the rifaximin group than in the placebo group had adequate relief of global IBS symptoms during the first 4 weeks after treatment (40.8% vs. 31.2%) N Engl J Med 2011; 364:22-32 January 6, 2011
The Effect of a Nonabsorbed Oral Antibiotic (Rifaximin) on the Symptoms of
the Irritable Bowel Syndrome
Mark Pimentel, MD; Sandy Park, BA; James Mirocha; Sunanda V. Kane, MD; and Yuthana Kong, MPH
Annals of Internal Med 17 October 2006 | Volume 145 Issue 8 | Pages 557-563
Conclusions: Rifaximin 400 mg 3 times daily for 10 days improves IBS symptoms for up to 10 weeks after the discontinuation of therapy.